MELISA ARREGUIN: Open Payments
NPI 1417205683 · TULARE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 7 payments from 2 companies in 2025. Trend: 2023 $70 · 2024 $246 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $208 |
| GlaxoSmithKline, LLC. | 2 | $44 |
Products named: XPHOZAH 30 MG, IBSRELA, BENLYSTA, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
